|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
11.140 +0.320 (+2.957%) | 2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | |
| Turnover | 561,371 | 43.459% | 391,311 | 309,589 | 229,568 | 166,394 |
| Cost of Sales | (254,385) | 17.628% | (216,263) | (141,091) | (90,949) | (58,221) |
| Gross Profit | 306,986 | 75.372% | 175,048 | 168,498 | 138,619 | 108,173 |
| 2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (154,852) | 317.413% | (37,098) | (47,359) | (2,831) | (79,551) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (230) | 0 | 0 | (314) | |
| Profit / (Loss) before Taxation | (205,588) | -15.968% | (244,653) | (229,776) | (150,224) | (158,047) | |
| Taxation | (10,043) | 809.692% | (1,104) | (3,813) | (5,925) | (2,462) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 40,516 | -73.376% | 152,176 | 98,082 | 65,027 | 47,417 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (175,115) | 87.127% | (93,581) | (135,507) | (91,122) | (113,092) | |
| 2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | |
| Net Finance Costs / (Income) | 14,226 | -- | (12,403) | 84 | 378 | 1,640 |
| Depreciation & Amortisation | 40,295 | 13.437% | 35,522 | 30,020 | 23,006 | 14,052 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -8.270 | 86.261% | -4.440 | -6.480 | -4.610 | -6.010 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.571 | -- | 0.639 | -- | 0.485 | 0.492 |
| Remarks: | Real time quote last updated: 15/11/2024 09:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -175,115,000 |
| %Change | 87.127% |
| EPS / (LPS) | USD -0.083 |
| NBV Per Share ($) | USD 0.571 |